Ozempic, Zepbound, Wegovy, & the Future of Body Diversity: What We’re Losing in the Weight Loss Hype

In this solo episode, Dr. Marianne explores how the growing popularity of GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro is reshaping the body diversity movement. As weight loss drugs become more widely used and celebrated, messages of fat liberation and weight-inclusive care are being challenged in new and complex ways. Dr. Marianne discusses the cultural effects of GLP-1s, the pressure many people feel to conform to changing body ideals, and what this means for fat humans, eating disorder recovery, and those committed to body autonomy. This episode offers a compassionate and honest look at the grief, confusion, and questions arising in this new era. If you're navigating the intersection of weight stigma, eating disorders, and the rise of GLP-1 medications, this conversation will help you feel grounded, supported, and less alone. 🔗 Learn more about the Binge Eating Recovery Membership: drmariannemiller.com CHECK OUT OTHER EPISODES ON BODY DIVERSITY & BODY LIBERATION! Breaking Free: Body Liberation After Binge Eating Disorder on Apple & Spotify. Body Acceptance, Size Diversity, & Body Liberation on Apple & Spotify. Body Liberation, Intersectionality, & Soul Work on Apple & Spotify. INTERESTED IN HANGING OUT MORE IN DR. MARIANNE-LAND? Follow me on Instagram @drmariannemiller Check out my virtual, self-paced ARFID and Selective Eating course Look into my self-paced, virtual, anti-diet, subscription-based curriculum. It is called Dr. Marianne-Land's Binge Eating Recovery Membership. Live in California, Texas, or Washington D.C. and interested in eating disorder therapy with me? Sign up for a free, 15-minute phone consultation HERE or via my website, and I'll get you to where you need to be! Check out my blog. Want more information? Email me at [email protected]